1-6 of 6
Eric Sievers, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multiple Complete Responses in a Phase 1 Dose-Escalation Study of the Antibody-Drug Conjugate SGN-35 in Patients with Relapsed or Refractory CD30-Positive Lymphomas.

Anas Younes, MD, Andres Forero-Torres, MD, Nancy L. Bartlett, MD, John P. Leonard, MD, Carmel Lynch, PhD, Dana A. Kennedy, PharmD, Eric Sievers, MD
Journal: Blood
Blood (2008) 112 (11): 1006.
https://doi.org/10.1182/blood.V112.11.1006.1006
Published: 2008
Journal Articles

Clinical and Serologic Interleukin 2 Receptor α Response to Interleukin-2 in CCG-2961, a Ranomized Phase 3 Trial for Pediatric Acute Myeloid Leukemia.

Beverly Lange, MD, Richard K Yang, Jacek Gan, PhD, Jaqueline A Hank, PhD, Eric Sievers, MD, Robert Gerbing, Todd Alonzo, PhD, Paul M Sondel, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 959.
https://doi.org/10.1182/blood.V112.11.959.959
Published: 2008
Journal Articles

SGN-30 (Anti-CD30 mAb) Has a Single-Agent Response Rate of 21% in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma (ALCL).

Andres Forero-Torres, MD, STeven H. Bernstein, MD, Ajay Gopal, MD, Francine Foss, MD, John P. Leonard, MD, Joseph D. Rosenblatt, MD, Nancy L. Bartlett, MD, Bruce D. Cheson, MD, Elliot Epner, MD, Francisco J. Hernandez-Ilizaliturri, MD, STephen J. Proctor, MD, Pauline Brice, MD, Herve Tilly, MD, Corinne Haioun, MD, Mats Jerkeman, MD, Andre Bosly, MD, Alessandro M. Gianni, MD, Harald Holte, MD, Premini Mahendra, MD, Lutz Uharek, MD, Jennie Lorenz, Jeremy Barton, MD, Eric Sievers, MD
Journal: Blood
Blood (2006) 108 (11): 2718.
https://doi.org/10.1182/blood.V108.11.2718.2718
Published: 2006
Journal Articles

Phase II Preliminary Results of SGN-30 (Anti-CD30 mAb) in Patients with CD30+ Lymphoproliferative Disorders.

Madeleine Duvic, MD, Youn Kim, MD, Sunil Reddy, MD, Andres Forero-Torres, MD, Lauren C. Pinter-Brown, MD, Mark U. Rarick, MD, John Zic, MD, Sophie Worobec, MD, Neil Korman, MD, Timothy Kuzel, MD, Kimberly Bohjanen, MD, Karen Flessland, Jeremy Barton, MD, Eric Sievers, MD
Journal: Blood
Blood (2006) 108 (11): 2733.
https://doi.org/10.1182/blood.V108.11.2733.2733
Published: 2006
Journal Articles

A Phase I/II Study of TACI-Ig To Neutralize APRIL and BLyS in Patients with Refractory or Relapsed Multiple Myeloma or Active Previously-Treated Waldenström’s Macroglobulinemia.

Jean-Francois Rossi, MD, Isabelle Borghini-Fuhrer, PhD, Jerôme Moreaux, Guilhem Requirand, Said Bouseida, Marie Picard, Arnaud Ythier, MD, Eric Sievers, MD, Bernard Klein, PhD
Journal: Blood
Blood (2005) 106 (11): 2566.
https://doi.org/10.1182/blood.V106.11.2566.2566
Published: 2005
Journal Articles

Mechanisms of IL-21 Enhancement of Rituximab Efficacy in a Lymphoma Xenograft Model.

Steve D. Hughes, PhD, Ken Bannink, Cecile Krejsa, PhD, Mark Heipel, Becky Johnson, Rick Holly, P.V. Sivakumar, PhD, Katherine Henderson, Chris Clegg, PhD, Eric Sievers, MD, Wayne Kindsvogel, PhD, Don Foster, PhD
Journal: Blood
Blood (2004) 104 (11): 1404.
https://doi.org/10.1182/blood.V104.11.1404.1404
Published: 2004